𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity

✍ Scribed by P. Musette; M. L. Brandi; P. Cacoub; J. M. Kaufman; R. Rizzoli; J.-Y. Reginster

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
243 KB
Volume
21
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The use of skin testing in the investiga
The use of skin testing in the investigation of cutaneous adverse drug reactions
✍ Barbaud; Reichert-Penetrat; TRΓ‰chot; Jacquin-Petit; Ehlinger; Noirez; Faure; Sch πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 370 KB

Skin testing with the suspected compound has been reported to be helpful in determining the cause of cutaneous adverse drug reactions (ADRs), but the value and specificity of these tests need to be determined. In this study, 72 patients with presumed drug eruptions (27 maculopapular, 18 urticarial,

A correlation of DNCB-induced delayed cu
A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer
✍ Thomas J. Cunningham; Dennis Daut; Patricia E. Wolfgang; Mary Mellyn; Susan Maci πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 538 KB

Delayed cutaneous hypersensitivity reactions to DNCB were performed before therapy i n 84 patients with recurrent breast cancer. Following sensitization, a lW+g challenge dose was graded as a strong, weak, or negative reaction. Thirty six patients were rechallenged 2 6 months with 100 +g of DNCB. Pa